Literature DB >> 16886951

Obesity and polycystic ovary syndrome.

T M Barber1, M I McCarthy, J A H Wass, S Franks.   

Abstract

The aetiology of Polycystic Ovary Syndrome (PCOS) is complex and multifactorial. There is much evidence, however, to suggest that adipose tissue plays an important role in the development and maintenance of PCOS pathology. There is a close correlation between adiposity and symptom severity in women with PCOS, and even modest reductions in weight generally translate into significant improvements in menstrual regularity, fertility and hyperandrogenic features. This review article considers the various mechanisms that might underlie this link between excess adiposity and PCOS - including the effects of differential insulin sensitivity, abnormal steroid hormone metabolism and adipocytokine secretion. Greater attention to the therapeutic options available to reduce the impact of excess adiposity on ovarian and metabolic function is essential to the management of PCOS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16886951     DOI: 10.1111/j.1365-2265.2006.02587.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  96 in total

1.  Euglena gracilis deoxyribonucleic acid polymerases: subcellular locations and variations during the cell cycle.

Authors:  A G McLennan; H M Keir
Journal:  Biochem Soc Trans       Date:  1975       Impact factor: 5.407

2.  Distribution of adiponectin multimeric forms in Chinese women with polycystic ovary syndrome and their relation to insulin resistance.

Authors:  Tao Tao; Edmond P Wickham; Wuqiang Fan; Jiejin Yang; Wei Liu
Journal:  Eur J Endocrinol       Date:  2010-06-07       Impact factor: 6.664

Review 3.  Association of endocrine disruptors and obesity: perspectives from epidemiological studies.

Authors:  E E Hatch; J W Nelson; R W Stahlhut; T F Webster
Journal:  Int J Androl       Date:  2010-01-22

4.  Interventional studies for polycystic ovarian syndrome in children and adolescents.

Authors:  Patricia Myriam Vuguin
Journal:  Ped Health       Date:  2010-02

5.  Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome.

Authors:  Leah D Whigham; Daniel E Butz; Hesam Dashti; Marco Tonelli; Luann K Johnson; Mark E Cook; Warren P Porter; Hamid R Eghbalnia; John L Markley; Steven R Lindheim; Dale A Schoeller; David H Abbott; Fariba M Assadi-Porter
Journal:  Curr Metabolomics       Date:  2014

6.  Prenatal programming by testosterone of hypothalamic metabolic control neurones in the ewe.

Authors:  K M Sheppard; V Padmanabhan; L M Coolen; M N Lehman
Journal:  J Neuroendocrinol       Date:  2011-05       Impact factor: 3.627

7.  Gonadal dysfunction in morbidly obese adolescent girls.

Authors:  Vivian Chin; Marisa Censani; Shulamit Lerner; Rushika Conroy; Sharon Oberfield; Donald McMahon; Jeffrey Zitsman; Ilene Fennoy
Journal:  Fertil Steril       Date:  2014-02-26       Impact factor: 7.329

8.  Androgen receptor antagonism and an insulin sensitizer block the advancement of vaginal opening by high-fat diet in mice.

Authors:  Diana S Brill; Suzanne M Moenter
Journal:  Biol Reprod       Date:  2009-07-15       Impact factor: 4.285

9.  Developmental programming: impact of prenatal testosterone excess on insulin sensitivity, adiposity, and free fatty acid profile in postpubertal female sheep.

Authors:  A Veiga-Lopez; J Moeller; D Patel; W Ye; A Pease; J Kinns; V Padmanabhan
Journal:  Endocrinology       Date:  2013-03-24       Impact factor: 4.736

Review 10.  Mediators of inflammation in polycystic ovary syndrome in relation to adiposity.

Authors:  Thozhukat Sathyapalan; Stephen L Atkin
Journal:  Mediators Inflamm       Date:  2010-04-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.